Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Eculizumab biosimilar by ISU ABXIS for Autoimmune Disorders: Likelihood of Approval
Eculizumab biosimilar is under clinical development by ISU ABXIS and currently in Phase I for Autoimmune Disorders. According to GlobalData,...